Histogen (FRA:CPH) Other Current Liabilities : €0.74 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Histogen Other Current Liabilities?

Histogen's other current liabilities for the quarter that ended in Sep. 2023 was €0.74 Mil.

Histogen's quarterly other current liabilities declined from Mar. 2023 (€0.29 Mil) to Jun. 2023 (€0.13 Mil) but then increased from Jun. 2023 (€0.13 Mil) to Sep. 2023 (€0.74 Mil).

Histogen's annual other current liabilities declined from Dec. 2020 (€0.68 Mil) to Dec. 2021 (€0.31 Mil) and declined from Dec. 2021 (€0.31 Mil) to Dec. 2022 (€0.15 Mil).

Histogen Other Current Liabilities Historical Data

The historical data trend for Histogen's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Histogen Other Current Liabilities Chart

Histogen Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Other Current Liabilities

Histogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Current Liabilities	Get a 7-Day Free Trial													-	-	-	-	-

Histogen Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Histogen Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Histogen's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Histogen (FRA:CPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Histogen Inc (FRA:CPH) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

HSTO:USA

Address

10655 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121

Website

https://www.histogen.com

Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.

Histogen (FRA:CPH) Headlines

No Headlines